HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Young-Bae Park Selected Research

gambi-jung

9/2021Therapeutic effects of Gambi-jung for the treatment of obesity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Young-Bae Park Research Topics

Disease

24Myocardial Infarction
01/2020 - 03/2004
11Hyperplasia
11/2016 - 08/2003
10Thrombosis (Thrombus)
11/2016 - 01/2008
10Infarction (Infarctions)
10/2014 - 03/2004
8Cardiovascular Diseases (Cardiovascular Disease)
03/2014 - 06/2004
8Ischemia
03/2010 - 01/2006
7Hypoxia (Hypoxemia)
09/2012 - 05/2006
7Coronary Artery Disease (Coronary Atherosclerosis)
09/2012 - 01/2002
6Pathologic Constriction (Stenosis)
10/2012 - 07/2005
5Vascular System Injuries
11/2016 - 07/2006
5Chronic Renal Insufficiency
02/2012 - 03/2008
4Renal Insufficiency (Renal Failure)
10/2013 - 09/2006
4Death (Near-Death Experience)
01/2013 - 06/2010
4Heart Failure
12/2010 - 08/2005
4Neointima
04/2009 - 08/2003
3Vascular Diseases (Vascular Disease)
01/2016 - 06/2009
3Hypertension (High Blood Pressure)
10/2013 - 05/2002
3Hyperemia
06/2012 - 08/2005
3ST Elevation Myocardial Infarction
02/2011 - 06/2007
3Inflammation (Inflammations)
01/2011 - 12/2003
3Myocardial Ischemia (Ischemic Heart Diseases)
03/2010 - 04/2006
2Obesity
09/2021 - 01/2011
2Diabetes Mellitus
07/2016 - 02/2012
2Fibrosis (Cirrhosis)
09/2015 - 09/2009
2Type 2 Diabetes Mellitus (MODY)
10/2013 - 01/2013
2Mitral Valve Insufficiency (Mitral Regurgitation)
06/2013 - 01/2013
2Atherosclerosis
01/2013 - 01/2011
2Left Ventricular Dysfunction
06/2011 - 03/2010
2Starvation
01/2009 - 02/2008
2Hypertrophy
10/2006 - 01/2006
1Weight Gain
09/2021
1Weight Loss (Weight Reduction)
01/2021
1Cardiac Arrhythmias (Arrythmia)
01/2020
1Vascular Remodeling
07/2016
1Diabetic Retinopathy (Retinopathy, Diabetic)
07/2016
1Wounds and Injuries (Trauma)
01/2016
1Cardiomegaly (Heart Hypertrophy)
09/2015
1Low Back Pain (Lumbago)
09/2015
1Pathologic Neovascularization
04/2014
1Dyslipidemias (Dyslipidemia)
10/2013

Drug/Important Bio-Agent (IBA)

9Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2014 - 03/2004
4Brain Natriuretic Peptide (Natrecor)FDA Link
06/2013 - 12/2010
4Proteins (Proteins, Gene)FDA Link
01/2012 - 08/2005
4Paclitaxel (Taxol)FDA LinkGeneric
08/2011 - 07/2006
3Therapeutic UsesIBA
09/2021 - 06/2009
3Pharmaceutical PreparationsIBA
09/2021 - 10/2010
3Streptozocin (Streptozotocin)FDA Link
07/2016 - 03/2010
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2016 - 06/2013
3Simvastatin (Zocor)FDA LinkGeneric
10/2013 - 02/2008
3Biomarkers (Surrogate Marker)IBA
06/2013 - 10/2007
3Clopidogrel (Plavix)FDA Link
09/2012 - 12/2011
3C-Reactive ProteinIBA
09/2012 - 06/2011
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2012 - 01/2006
3Adenosine (Adenocard)FDA LinkGeneric
06/2012 - 08/2005
3CytokinesIBA
01/2012 - 02/2008
3Thalidomide (Thalomid)FDA Link
10/2010 - 05/2004
3Celecoxib (Celebrex)FDA Link
06/2010 - 07/2004
3LipidsIBA
02/2008 - 03/2005
3erucylphosphocholineIBA
02/2008 - 07/2006
2Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA
11/2016 - 11/2013
2Cadherins (E-Cadherin)IBA
07/2016 - 01/2012
2Glucose (Dextrose)FDA LinkGeneric
07/2016 - 04/2014
2matrigelIBA
01/2016 - 10/2014
2Rosiglitazone (Avandia)FDA Link
11/2013 - 04/2009
2LDL CholesterolIBA
10/2013 - 06/2005
2Apolipoprotein A-I (Apolipoprotein A1)IBA
10/2013 - 06/2005
2ApolipoproteinsIBA
10/2013 - 06/2005
2Atorvastatin (Lipitor)FDA Link
10/2013 - 01/2013
2Sirolimus (Rapamycin)FDA Link
08/2011 - 01/2009
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
03/2010 - 09/2009
2Ergonovine (Ergometrine)IBA
03/2010 - 04/2006
2Glycogen Synthase Kinase 3 betaIBA
04/2009 - 08/2003
2Glycogen Synthase (Synthase I)IBA
04/2009 - 08/2003
2MetalsIBA
01/2008 - 07/2006
2E-SelectinIBA
12/2007 - 05/2006
2Forkhead Transcription Factors (Forkhead Box Proteins)IBA
02/2007 - 04/2005
2Cyclin D1IBA
10/2006 - 01/2006
2beta CateninIBA
10/2006 - 01/2006
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
07/2006 - 05/2006
2CholesterolIBA
06/2005 - 03/2005
1gambi-jungIBA
09/2021
1sulindac sulfone (exisulind)IBA
11/2016
1cadherin 5IBA
07/2016
1Retinaldehyde (Retinal)IBA
07/2016
1udenafilIBA
09/2015
1Phosphodiesterase 5 InhibitorsIBA
09/2015
1Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
09/2015
1LDL Lipoproteins (beta Lipoproteins)IBA
10/2013
1Ezetimibe (Zetia)FDA Link
10/2013

Therapy/Procedure

16Stents
11/2016 - 08/2005
10Therapeutics
01/2013 - 03/2004
8Drug-Eluting Stents
11/2016 - 01/2008
6Percutaneous Coronary Intervention
10/2012 - 01/2002
5Transplantation
12/2013 - 03/2008
2Catheter Ablation
01/2020 - 04/2011
2Stem Cell Transplantation
07/2008 - 03/2004
1Caloric Restriction
01/2021
1Micro-Electrical-Mechanical Systems
09/2015
1Cell- and Tissue-Based Therapy (Cell Therapy)
09/2014
1Continuous Renal Replacement Therapy
10/2013